HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2- (3- (4- ((2,6- dimethylmorpholino)methyl)styryl)- 1H- indazol- 6- yl)- 5'- methoxyspiro(cyclopropane- 1,3'- indolin)- 2'- one

a polo-like kinase 4 inhibitor with antineoplastic activity; structure in first source
Also Known As:
CFI-400945
Networked: 15 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cescon, David W: 5 articles (03/2022 - 08/2014)
2. Mak, Tak W: 4 articles (01/2019 - 08/2014)
3. Bray, Mark R: 3 articles (03/2022 - 08/2014)
4. Thu, Kelsie L: 2 articles (03/2022 - 01/2018)
5. Slamon, Dennis J: 2 articles (01/2019 - 01/2019)
6. Liu, Hong-Min: 2 articles (01/2016 - 01/2015)
7. Qi, Ping-Ping: 2 articles (01/2016 - 01/2015)
8. Yu, Bin: 2 articles (01/2016 - 01/2015)
9. Bian, Shirong: 1 article (06/2022)
10. Liao, Chenzhong: 1 article (06/2022)

Related Diseases

1. Neoplasms (Cancer)
2. Vascular Diseases (Vascular Disease)
3. Myelodysplastic Syndromes (Myelodysplastic Syndrome)
4. Myeloid Leukemia (Leukemia, Myelocytic)
5. Polyploidy

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. DNA (Deoxyribonucleic Acid)
3. Propidium (Propidium Iodide)
4. Doxorubicin (Adriamycin)
5. Apolipoproteins E (ApoE)
6. Antineoplastic Agents (Antineoplastics)
7. Spirooxindoles
8. RO8994
9. centrinone
10. SAR405838

Related Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Oral Administration